BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32384154)

  • 1. The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.
    Enns CA; Jue S; Zhang AS
    Blood; 2020 Aug; 136(8):989-1001. PubMed ID: 32384154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matriptase-2 regulates iron homeostasis primarily by setting the basal levels of hepatic hepcidin expression through a nonproteolytic mechanism.
    Enns CA; Weiskopf T; Zhang RH; Wu J; Jue S; Kawaguchi M; Kataoka H; Zhang AS
    J Biol Chem; 2023 Oct; 299(10):105238. PubMed ID: 37690687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage.
    Enns CA; Ahmed R; Zhang AS
    J Biol Chem; 2012 Oct; 287(42):35104-35117. PubMed ID: 22893705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates
    Pettinato M; Aghajan M; Guo S; Bavuso Volpe L; Carleo R; Nai A; Pagani A; Altamura S; Silvestri L
    Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G310-G317. PubMed ID: 38252872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of matriptase-2 (TMPRSS6) in iron metabolism.
    Lee P
    Acta Haematol; 2009; 122(2-3):87-96. PubMed ID: 19907145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome analysis reveals TMPRSS6 isoforms with distinct functionalities.
    Dion SP; Béliveau F; Désilets A; Ghinet MG; Leduc R
    J Cell Mol Med; 2018 Apr; 22(4):2498-2509. PubMed ID: 29441715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats.
    Frýdlová J; Přikryl P; Truksa J; Falke LL; Du X; Gurieva I; Vokurka M; Krijt J
    PLoS One; 2016; 11(2):e0148540. PubMed ID: 26845567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane serine protease 6, a novel target for inhibition of neuronal tumor growth.
    Zuo Y; Bai J; Bai H; Tian S; Sun H; Shi Z; Yu P; Gao G; Li Y; Chang YZ
    Cell Death Dis; 2024 Jan; 15(1):49. PubMed ID: 38218852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
    Casu C; Pettinato M; Liu A; Aghajan M; Lo Presti V; Lidonnici MR; Munoz KA; O'Hara E; Olivari V; Di Modica SM; Booten S; Guo S; Neil G; Miari R; Shapir N; Zafir-Lavie I; Domev H; Ferrari G; Sitara D; Nai A; Rivella S
    Blood; 2020 Oct; 136(17):1968-1979. PubMed ID: 32556142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte neogenin is required for hemojuvelin-mediated hepcidin expression and iron homeostasis in mice.
    Enns CA; Jue S; Zhang AS
    Blood; 2021 Aug; 138(6):486-499. PubMed ID: 33824974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis proteins are dispensable for the acute hepcidin response to BMP2.
    Pagani A; Pettinato M; Colucci S; Dulja A; Rauner M; Nai A; Camaschella C; Altamura S; Muckenthaler MU; Silvestri L
    Haematologica; 2020 Oct; 105(10):e493. PubMed ID: 33054090
    [No Abstract]   [Full Text] [Related]  

  • 12. Normal and dysregulated crosstalk between iron metabolism and erythropoiesis.
    Ginzburg Y; An X; Rivella S; Goldfarb A
    Elife; 2023 Aug; 12():. PubMed ID: 37578340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II Transmembrane Serine Proteases as Modulators in Adipose Tissue Phenotype and Function.
    Wu Q; Li S; Zhang X; Dong N
    Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing the Dual Nature of Iron to Preserve Health.
    Silvestri L; Pettinato M; Furiosi V; Bavuso Volpe L; Nai A; Pagani A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Hemojuvelin and Ferritin: Potential Prognostic Markers in Pediatric Hematopoietic Cell Transplantation.
    Styczyński J; Słomka A; Łęcka M; Albrecht K; Romiszewski M; Pogorzała M; Kubicka M; Kuryło-Rafińska B; Tejza B; Gadomska G; Kolańska-Dams E; Michalska M; Żekanowska E
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.
    Ganz T; Nemeth E; Rivella S; Goldberg P; Dibble AR; McCaleb ML; Guo S; Monia BP; Barrett TD
    Adv Ther; 2023 Apr; 40(4):1317-1333. PubMed ID: 36690839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common Single Nucleotide Polymorphism of
    Suksangpleng T; Glomglao W; Viprakasit V
    Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally impaired isoforms regulate TMPRSS6 proteolytic activity.
    Dion SP; Désilets A; Lemieux G; Leduc R
    PLoS One; 2022; 17(8):e0273825. PubMed ID: 36044454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin and Iron in Health and Disease.
    Nemeth E; Ganz T
    Annu Rev Med; 2023 Jan; 74():261-277. PubMed ID: 35905974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS13 zymogen activation, surface localization, and shedding is regulated by proteolytic cleavage within the non-catalytic stem region.
    Martin CE; Murray AS; Mackinder JR; Sala-Hamrick KE; Flynn MG; Lundgren JG; Varela FA; List K
    Biol Chem; 2022 Sep; 403(10):969-982. PubMed ID: 35796294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.